Back to results
US 6,001,352 AGranted
Resurfacing cartilage defects with chondrocytes proliferated without differentiation using platelet-derived growth factor
AssigneeOsteoBiologics, Inc.
InventorsBarbara D. Boyan, Zvi Schwartz
Life of this patent
Estimating the term…
Abstract
A method for stimulating chondrocyte proliferation and inhibiting chondrocyte differentiation along the endochondral developmental pathway is provided comprising contacting condrocytes with an effective amount of Platelet-Derived Growth Factor (PDGF) such as PDGF-BB, PDGF-AA OR PDGF-AB in the substantial absence of growth factors which promote cell differentiation. This allows such cells to be multiplied in culture for loading onto a scaffolding material and implanting into a cartilage or bone wound.
Claims2
A method for resurfacing an articular cartilage defect in a patient comprising:
- (a) isolating chondrocyte cells from the patient;
- (b) contacting said cells with a Platelet-Derived Growth Factor (PDGF) selected from the group consisting of PDGF-BB, PDGF-AA and PDGF AB for about 30 minutes to about 24 hours in an amount effective to inhibit chondrocyte endochondral maturation to hypertrophic and in the substantial absence of growth factors which promote the hypertrophic stage of cell differentiation;
- (c) loading said cells onto a cell scaffolding material;
- and
- (d) placing said cell scaffolding material in said defect.
2 more elements
Dependencies are inferred from the claim text.